Protara Therapeutics (TARA) Net Income towards Common Stockholders: 2013-2014
Historic Net Income towards Common Stockholders for Protara Therapeutics (TARA) over the last 2 years, with Dec 2014 value amounting to -$9.7 million.
- Protara Therapeutics' Net Income towards Common Stockholders was N/A to $5.9 million in Q4 2014 from the same period last year, while for Dec 2014 it was -$10.3 million, marking a year-over-year change of. This contributed to the annual value of -$9.7 million for FY2014, which is 30.90% up from last year.
- Latest data reveals that Protara Therapeutics reported Net Income towards Common Stockholders of -$9.7 million as of FY2014, which was up 30.90% from -$14.0 million recorded in FY2013.
- Protara Therapeutics' Net Income towards Common Stockholders' 5-year high stood at -$9.7 million during FY2014, with a 5-year trough of -$14.0 million in FY2013.
- For the 2-year period, Protara Therapeutics' Net Income towards Common Stockholders averaged around -$11.9 million, with its median value being -$11.9 million (2013).
- Data for Protara Therapeutics' Net Income towards Common Stockholders shows a peak YoY skyrocketed of 30.90% (in 2014) over the last 5 years.
- Yearly analysis of 2 years shows Protara Therapeutics' Net Income towards Common Stockholders stood at -$14.0 million in 2013, then skyrocketed by 30.90% to -$9.7 million in 2014.